Recommendations for using opioids in chronic non-cancer pain

European Journal of Pain

Volumn 7, Issue 5, 2003, Pages 381-386

  Kalso, Eija ⁱ   Allan, Laurie ^a   Dellemijn, Paul L I ^b   Faura, Clara C ^c   Ilias, Wilfried K ^d   Jensen, Troels S ^e   Perrot, Serge ^f   Plaghki, Leon H ^g   Zenz, Michael ^h  

^a ST MARK S HOSPITAL   (United Kingdom)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d St John of God Hospital   (Austria)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f Paris Descartes University   (France)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ NONE

Author keywords

Guideline; Noncancer pain; Opiates; Opioids

Indexed keywords

NARCOTIC ANALGESIC AGENT; OPIATE;

ANALGESIA; CHRONIC PAIN; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; DRUG FORMULATION; DRUG PREFERENCE; HUMAN; PAIN; PATIENT MONITORING; PATIENT REFERRAL; PATIENT RIGHT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUSTAINED RELEASE PREPARATION;

EID: 0041909442     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(02)00143-X     Document Type: Article

References (34)

1. Allan L, Hays H, Jensen N-H, Le Polain de Waroux B, Bolt M, Donald R, Kalso E. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1-7.
2. American Academy of Pain Medicine. The use of opioids for the treatment of chronic pain, 1996, www.painmed.org/productpub/statements/opioidstmt.html, Accessed 30 May 2002.
3. American Academy of Pain Medicine. Long-term controlled substances therapy for chronic pain. Sample agreement, 2001, www.painmed.org/productpub/statements/sample.html, 30th May 2002.
4. American Academy of Pain Medicine. Consent for chronic opioid therapy, 2002, www.painmed.org/productpub/statements/opioidconsent.html, 30th May 2002.
5. Attal N, Guirimand F, Rasseur L, Gaude V, Chauvin C, Bouhassira D. Effects of IV morphine in central pain. Neurology 2002;58:554-63.
6. Caldwell JR, Hale ME, Boyd RE, Hague JM, Iwan T, Shi M, Lacoutre PG. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-9.
7. Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Sanford HR, Yuan W, Eliot L, Babul N, Mikkelsen P. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91.
8. Dellemijn PLI, van Duijn H, Vanneste JAL. Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 1998;16:220-9.
9. Dellemijn PLI, Vanneste JAL. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997;349:753-8.
10. Do Quang-Cantagrel N, Wallace MS, Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesth Analg 2000;90:933-7.
11. Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999;18:27-37.
12. Follett KA. The fallacy of using a solitary outcome measure as the standard for satisfactory pain treatment outcome. Pain Forum 1999;8(4):189-91.
13. Gitlin MC. Contracts for opioid administration for the management ofchronic pain: a reappraisal. J Pain Symptom Manage 1999;18:68.
14. Gardner-Nix JS. Oral methadone for managing chronic nonmalignant pain. J Pain Symptom Manage 1996;11:321-8.
15. Harke H, Gretenkort P, Ladleif HK, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. [Clinical Trial, Journal Article, Randomized Controlled Trial.] Anesthesia & Analgesia 2001;92(2):488-95.
16. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90:4755.
17. Jadad AD, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995;274:1870-3.
18. Kalso E, Paakkari P, Stenberg I, editors. Opioids in chronic non-cancer pain, situation and guidelines in Nordic countries. Finland, Helsinki: National Agency for Medicines; 1999.
19. Large RG, Schug SA. Opioids for chronic pain of non-malignant origin-caring or crippling. Health Care Anal 1995;3:5-11.
20. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain-results of a double-blind placebo-controlled trial (MONTAS). Pain 2002;97:223-33.
21. Melzack R. The tragedy of needless pain. Sci Am 1990;262:19-25.
22. Milligan K, Lanteri-Minet M, Borchert K, Helmers H, Donald R, Kress H-G, Adiaensen H, Moulin D, Järvimäki V, Haazen L. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001;2:197-204.
23. Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Mershey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-7.
24. National Agency for Medicines Sweden. Använding av opioider vid längvarig icke-cancerrelaterad smärta-rekommendationer. Information Från Läkemedelsverket 2002;13:17-75.
25. Peat S, Sweet P, Miah Y, Barklamb M, Larsen U. Assessment of analgesia in human chronic pain. Randomized double-blind cross-over study of once daily Repro-Dose morphine versus MST Continus. Eur J Clin Pharmacol 1999;55:577-81.
26. Perrot S, Bannwarth B, Bertin P, Javier RM, Glowinski J, Le Bars M, Treves R. Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology. Rev Rhum Engl Ed 1999;66(11):571-6.
27. Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, Rutstein J, Lacoutre PG. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Arch Intern Med 2000;160:853-60.
28. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
29. Rowland, Torgerson. What outcomes should be measured? BMJ 1998;317.
30. Thomsen AB, Becker N, Eriksen J. Opioid rotation in chronic non-malignant pain patients. Acta Anaesthesiol Scand 1999;43:909-17.
31. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain. A randomised trial in postherpetic neuralgia. Neurology 1998;50:1837-41.
32. Woolf C, Bennett G, Doherty M. Towards a mechanism-based classification of pain?. Pain 1998;77:227-9.
33. World Health Organization. Cancer pain relief, WHO, Geneva; 1996.
34. Zenz M, Willweber-Strumpf A. Opiodphobia and cancer pain in Europe. Lancet 1993;341:1075-6.